Microbial Biofilm in the Development of Wound Process

Capa

Citar

Texto integral

Resumo

The article reviews data from Russian and international literature highlighted the effect of microbial biofilms on the course of the wound process. The composition of biofilms of various microorganisms and their relations within the polysaccharide matrix are given in detail. The role of biofilms in the development of microorganism resistance to antibacterial therapy and prolongation of the inflammatory process is emphasized. It is evidenced that they cause transition of the acute phase of the wound process into the chronic one.

Sobre autores

Boris Sukovatykh

Kursk state medical University

Email: SukovatykhBS@kursksmu.net
ORCID ID: 0000-0003-2197-8756

M.D., Professor, the head of the department of General Surgery

Rússia, Russian Federation, 305041, Kursk, Karl Marx str., 3

Arsen Grigoryan

Kursk State Medical University

Email: grigorjanau@kursksmu.net
ORCID ID: 0000-0002-5039-5384

Ph.D, Ass. Professor of Department of Operative Surgery and Topographic Anatomy named after prof. A.D. Myasnikov

Rússia, Russian Federation, 305041, Kursk, Karl Marx str., 3

Aleksandr Begin

Federal state budget educational institution of higher health care of the Kursk state medical university of the ministry of health of Russia, Kursk, Russia

Autor responsável pela correspondência
Email: abezin@yandex.ru
ORCID ID: 0000-0003-3776-9449
Código SPIN: 1250-5549

M.D., Professor, head of the department of operative surgery and topographic anatomy named after A. D. Myasnikov, Kursk state medical university

Rússia, Kursk, Russian Federation

Bibliografia

  1. Burnham JP, Kollef MH. Treatment of severe skin and soft tissue infections: a review. Curr Opin Infect Dis. 2018; 31 (2): 113-119. doi: 10.1097/QCO.0000000000000431
  2. Golan Y. Current Treatment Options for Acute Skin and Skin-structure Infections. Clin Infect Dis. 2019; 68 (3): 206-212. doi: 10.1093/cid/ciz004
  3. Gidirim GP, Prisekaru IV, Bagyan GV, Chapter NA. Clinical results of treatment of purulent wounds of skin and soft tissues with antiseptic "Isofural" (solution). Meditsinskii al'manakh. 2018; 4 (55): 114-116. doi: 10.21145/2499-9954-2018-4-114-116. (in Russ.)
  4. 4.Balin V.N., Karshiev H.K., Muzikin M.I., Iordanishvili A.K. Endogenous intoxication with various methods of treatment of common phlegmon (preclinical study). Kurskii nauchno-prakticheskii vestnik "Chelovek i ego zdorov'e". 2017; 1: 77-80. doi: 10.21626/vestnik/2017-1/14. (in Russ.)
  5. Katorkin SE, Bystrov SA, Lisin OE, Rozanova AA, Bezborodov AI. Evaluation of the effectiveness of the use of modern dressings in the complex treatment of purulent wounds. Ambulatornaya khirurgiya. 2019; 1-2: 146-152. doi.org/10.21518/1995-1477-2019-1-2-146-152. (in Russ.)
  6. Shukla SK, Sharma AK, Gupta V, Yashavarddhan MH. Pharmacological control of inflammation in wound healing. J. Tissue Viability. 2019;28:218–222. doi: 10.1016/j.jtv.2019.09.00
  7. Alhede M, Alhede M. The biofilm challenge. EWMA Journal. 2014; 14(1): 1-5.
  8. Percival SL, McCarty SM, Lipsky B. Biofilms and wounds: an overview of the evidence. Adv. Wound Care (New Rochelle). 2015; 4(7): 373-381.
  9. Sukhina MA, Kalashnikova IA, Kashnikov VN, Veselov AV, Mikhalevskaya VI, Piyadina AYu. The effect of antibacterial substances on the growth of biofilm of clinical insulators. Koloproktologiya. 2018; 64(2): 78-84. (in Russ.)
  10. Afinogenova AG, Darovskaya EN. Microbial biofilms of the Russian Academy of Sciences: the state of the question. Travmatologiya i ortopediya Rossii. 2011;61(3):119–125. (in Russ.)
  11. Shlepotina NM, Timakova VA. The use of suture material and the development of infections in the field of surgical intervention: the view of N.I. Pirogov and the current state of the problem. Vestnik Soveta molodykh uchenykh i spetsialistov Chelyabinskoi oblasti. 2016; 3(4):159-161. (in Russ.)
  12. Bublik EV, Korshunova YuV, Krupinova YuA, Morozova OA. Pathogenetic aspects of local treatment of diabetic foot syndrome. The new alginate bandage FIBROCLEAN AG: what are the advantages? Wounds and wound infections. Zhurnal imeni prof. B.M. Kostyuchenka. 2015;. 2.(1): 20-25. (in Russ.)
  13. Chekmareva IA, Mitish VA, Paklina OV, Blatun LA, Paskhalova YS, Ushakov AA, Terekhova RP, Gordienko EN, Sokov SL, Munoz Cepeda PA, Kachanzhi AP. Morphological evaluation of the effectiveness of the VERSAJET ® hydrosurgical system in combination with combined antibacterial therapy in the treatment of purulent-necrotic complications of diabetic foot syndrome with biofilm forms of bacteria. Wounds and wound infections. Zhurnal imeni prof. B.M. Kostyuchenka. 2015; 2( 3): 8-21. (in Russ.)
  14. Percival SL. Biofilms in Infection Prevention and Control. A Health-care Handbook. Academic Press. 2014;127-139. doi.org/10.1016/b978-0-12-397043-5.00008-6
  15. Cooper RА, Bjarnsholt T, Alhede M. Biofilms in wounds: a review of present knowledge. Journal of Wound Care. 2014; 23(11):570-582. doi.org/10.12968/jowc.2014.23.11.57.
  16. T.Tolker-Nielsen Development and dynamics of Pseudomonas sp. biofilms. Journal of bacteriology. 2000; 182( 22):6482-6489.
  17. Percival SL, Hill KE, Williams DW. A review of the scientific evidence for biofilms in wounds. Wound Repair Regen. 2012; 20: 647-657.
  18. Yarets YuI. Chronic wound infection: modern concepts and diagnostic approaches. Zdravookhranenie (Minsk). 2016; 7: 39-42. (in Russ.)
  19. Weigel LM. High-level vancomycinresistant Staphylococcus aureus isolates associated with a polymicrobial biofilm. Antimicrobial agents and chemotherapy. 2007; 51(1): 231-238.
  20. Barsoumian AE, Mende K, Sanchez JC, Beckius ML, Wenke JC, Curray CK, Akers KS. Clinical infectious outcomes associated with biofilm-related bacterial infections: a retrospective chart review. BMC Infectious Diseases. 2015; 15:223 -228.doi.10.1186/s12879-015-0972-2
  21. Mulla S,Kumar A, Rajdev S.Comparison of MIC with MBEC assay for in vitro antimicrobial susceptibility testing in biofilm forming clinical bacterial isolates. Advances in Microbiology. 2016; 6( 02):73-75.
  22. Pastar I, Nusbaum AG, Gil J. Interactions of methicillin resistant Staphylococcus aureus USA300 and Pseudomonas aeruginosa in polymicrobial wound infection. PLoS One. 2013; 8(2): e5684
  23. Fazli M, Bjarnsholt T, Kirketerp-Moller K. Quantitative analysis of the cellular inammatory response against biolm bacteria in chronic wounds. Wound Repair Regen. 2011; 19(3): 387-391.
  24. Carvalhais V. An immunoproteomic approach for characterization of dormancy within Staphylococcus epidermidis biofilms. Mol. Immunol. 2015 ; 65 (2):429–435.
  25. Wolcott R, Dowd S. The role of biofilms: are we hitting the right target? Current concepts in wound Healing: Update. Plastic and reconstructive surgery. 2011; 127 ( 1): 28—37.
  26. Okulich VK. Microbiological and immunological aspects of infections caused by opportunistic bacteria forming biofilm. Vestnik Vitebskogo gosudarstvennogo meditsinskogo universiteta. 2016; 15( 5.): 5-8. (in Russ.)
  27. Ciofu O. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response APMIS. Supplementum. 2003; 116: 1-47.
  28. Mengi S, Vohra P, Sawhney N, Singh VA. Biofilms: a diagnostic challenge in persistent infections. Int. J. Res. Med. Health Sci. 2013; 2(3): 1-9.
  29. Flemming HC, Wingender J. The biofilm matrix. Nature Reviews Microbiology. 2010;8(9):623-625.
  30. Kaplan A, Lee MW, Wolf AJ, Limon JJ, Becker CA, Ding M, Murali R., Lee EY, Liu GY, Wong GCL, Underhill DM. Direct Antimicrobial Activity of IFN-β. J Immunol. 2017;198: 4036-4045. doi: 10.4049/jimmunol.1601226
  31. Nair N, Biswas R, Gotz F, Biswas L. Impact of Staphylococcus aureus on Pathogenesis in Polymicrobial Infections. Infection and Immunity. 2014;82(6):2162-2169. doi.org/10.1128/iai.00059-14
  32. Dobrynina MA, Zurochka AV, Tyapaeva YaV, Belozertseva YuP, Gritsenko VA. Evaluation of the effect of the synthetic peptide of the active center of granulocyte-macrophage colony stimulating factor - ZP2 on the growth and biofilm formation of clinical isolates of enterobacteria in vitro. Byulleten' Orenburgskogo nauchnogo tsentra Ural'skogo otdeleniya Rossiiskoi akademii nauk. 2018; 4:17-22. doi. 10.24411/2304-9081 (in Russ.)
  33. Kostakioti M, Hadjifrangiskou M, Hultgren SJ. Bacterial biofilms: development, dispersal, and therapeutic strategies in the dawn of the postantibiotic era. Cold Spring Harb. Perspect. Med. 2013; 3 :a010306. doi.org/10.1101/cshperspect.a010306.
  34. Schultz G. S Wound bed preparation: a systemic approach to wound management. Wound Repair and Regeneration. 2013; 11( 1.) – Р. 1-28.

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML
Baixar


Creative Commons License
Este artigo é disponível sob a Licença Creative Commons Atribuição–NãoComercial–SemDerivações 4.0 Internacional.

Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).